We are live on ! Find out more
OA

Oxbow Advisors Portfolio holdings

AUM $1.18B
1-Year Est. Return 28.15%
This Fund
S&P 500
This Quarter Est. Return
+6.2%
1 Year Est. Return
+28.15%
3 Year Est. Return
+72.79%
5 Year Est. Return
+88.47%
10 Year Est. Return
+169.66%
AUM
$1.04B
AUM Growth
+$61.2M
Cap. Flow
+$6.12M
Cap. Flow %
0.59%
Top 10 Hldgs %
29.97%
Holding
314
New
24
Increased
85
Reduced
102
Closed
33

Sector Composition

Rank Sector Weight
1 Technology 14.18%
2 Energy 9.95%
3 Financials 7.48%
4 Communication Services 7.11%
5 Consumer Discretionary 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAX
26
abrdn Asia-Pacific Income Fund
FAX
$590M
$12.6M 1.21%
550,386
+4,093
+0.7% +$100K
MPT
27
Medical Properties Trust
MPT
$2.89B
$12.4M 1.19%
524,610
+46,704
+10% +$1M
KMI icon
28
Kinder Morgan
KMI
$73.1B
$12.2M 1.17%
770,426
-13,048
-2% -$217K
BSX.PRA
29
DELISTED
Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A
BSX.PRA
$12M 1.15%
+104,350
New +$11.9M
NKE icon
30
Nike
NKE
$61.9B
$11.7M 1.12%
70,259
+297
+0.4% +$49K
MPLX icon
31
MPLX
MPLX
$59.5B
$11.5M 1.1%
387,585
+5,386
+1% +$161K
NTR icon
32
Nutrien
NTR
$32.7B
$11.4M 1.09%
151,781
-2,672
-2% -$187K
PYPL icon
33
PayPal
PYPL
$49.5B
$10.8M 1.03%
57,240
+28,920
+102% +$6.26M
MMP
34
DELISTED
Magellan Midstream Partners, L.P.
MMP
$10.4M 1%
224,388
+2,607
+1% +$123K
MNRL
35
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$10.3M 0.99%
489,172
-750,227
-61% -$16.4M
DOC
36
DELISTED
PHYSICIANS REALTY TRUST
DOC
$10.2M 0.98%
543,489
+126,678
+30% +$2.33M
AMT icon
37
American Tower
AMT
$77.7B
$10.2M 0.98%
34,915
+3,029
+9% +$827K
MCO icon
38
Moody's
MCO
$81.7B
$10.1M 0.97%
25,939
+522
+2% +$201K
NEM icon
39
Newmont
NEM
$98.2B
$10M 0.96%
162,012
+35,242
+28% +$2M
DSTL icon
40
Distillate US Fundamental Stability & Value ETF
DSTL
$1.91B
$9.96M 0.95%
215,122
+5,119
+2% +$224K
OHI icon
41
Omega Healthcare
OHI
$15.4B
$9.62M 0.92%
325,142
-31,692
-9% -$925K
FNV icon
42
Franco-Nevada
FNV
$41.4B
$9.62M 0.92%
69,546
-7,337
-10% -$1.01M
MRK icon
43
Merck
MRK
$324B
$9.52M 0.91%
124,152
-1,146
-0.9% -$91.3K
DVY icon
44
iShares Select Dividend ETF
DVY
$24B
$9M 0.86%
73,416
+1,140
+2% +$136K
RYN icon
45
Rayonier
RYN
$6.49B
$8.87M 0.85%
242,287
-2,544
-1% -$88.5K
NVS icon
46
Novartis
NVS
$295B
$8.86M 0.85%
101,241
-1,479
-1% -$123K
LMT icon
47
Lockheed Martin
LMT
$134B
$8.8M 0.84%
24,751
-264
-1% -$91.3K
JPST icon
48
JPMorgan Ultra-Short Income ETF
JPST
$40B
$8.63M 0.83%
170,944
+8,130
+5% +$411K
AVGOP
49
DELISTED
Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A
AVGOP
$8.42M 0.81%
4,057
-6,363
-61% -$11.1M
CVX icon
50
Chevron
CVX
$388B
$7.22M 0.69%
61,518
-71,150
-54% -$8.08M

Similar funds

Oxbow Advisors's Q4 2021 Portfolio in Review

As of Q4 2021, Oxbow Advisors held 314 positions worth $1.04B, up 6.2% from $983M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Oxbow Advisors's Q4 2021 filing shows 24 new, 85 increased, 102 reduced and 33 closed positions. Its largest new stake was iShares 20+ Year Treasury Bond ETF: 422,499 shares worth $62.6M. The largest sale was Brigham Minerals, Inc. Class A Common Stock, an estimated $16.4M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Energy and Financials.

  • Oxbow Advisors's largest Q4 2021 buy was iShares 20+ Year Treasury Bond ETF: 422,499 shares worth $62.6M.
  • Oxbow Advisors added most to Charter Communications in Q4 2021, an estimated $8.22M increase.
  • Oxbow Advisors's biggest Q4 2021 reduction was Brigham Minerals, Inc. Class A Common Stock, cutting an estimated $16.4M.
  • Oxbow Advisors fully exited Healthcare Realty in Q4 2021, selling an estimated $8.69M.
  • Oxbow Advisors's ten largest holdings make up 30% of its $1.04B portfolio in Q4 2021.
  • Oxbow Advisors opened 24 new positions and closed 33 in Q4 2021.
  • Oxbow Advisors's portfolio value rose 6.2% quarter-over-quarter to $1.04B.

Based on Oxbow Advisors's 13F filing for Q4 2021, filed 9 Feb 2022.